Aktieanalys

Vicore: First Patients Included in Pivotal C21 Covid-19 Trial - Redeye

{newsItem.title}

Redeye Publicerad: 20 Sep 2021 11:51

We give a brief comment on the news that the first patients have been included in Vicore’s pivotal C21 Covid-19 Trial.

Länk till analysen i sin helhet: https://www.redeye.se/research/821004/vicore-first-patients-included-in-pivotal-c21-covid-19-trial?utm_source=finwire&utm_medium=RSS

Nyheter om Vicore Pharma

Läses av andra just nu

Om aktien Vicore Pharma

Senaste nytt